Medtronic (MDT) is warning doctors and patients to look at the company’s latest "defibrillator models because it was prone to a defect that has caused malfunctions in hundreds of patients and may have contributed to five deaths." The defect is tied to a wire between the device and the heart itself and may effect 235,000 patients according to The New York Times.
The news gets worse from there. "Replacing leads on a heart device like a defibrillator is considered by experts to be far more dangerous than replacing the device itself," the NYT writes.
So, that leaves patients and doctors between a rock and a hard place. Someone with the device can wait for the wire to fail and have surgery, or they can have the risky surgery first.
Liability class action attorneys will be having a look at this one.
Douglas A. McIntyre
Smart Investors Are Quietly Loading Up on These “Dividend Legends” (Sponsored)
If you want your portfolio to pay you cash like clockwork, it’s time to stop blindly following conventional wisdom like relying on Dividend Aristocrats. There’s a better option, and we want to show you. We’re offering a brand-new report on 2 stocks we believe offer the rare combination of a high dividend yield and significant stock appreciation upside. If you’re tired of feeling one step behind in this market, this free report is a must-read for you.
Click here to download your FREE copy of “2 Dividend Legends to Hold Forever” and start improving your portfolio today.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
